Samsung Biologics Plans $2 Billion Fundraising for PolyPeptide Acquisition
· gurufocus.com
Samsung Biologics aims to raise over $2 billion through a stock issuance to finance its planned acquisition of PolyPeptide Group and expand its manufacturing ca
Samsung Biologics aims to raise over $2 billion through a stock issuance to finance its planned acquisition of PolyPeptide Group and expand its manufacturing ca...